Britain's GSK to sell entire stake in Hindustan Unilever

FILE PHOTO: General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Matthew Childs

(Reuters) – GlaxoSmithKline (GSK.L) said on Thursday it agreed to sell its entire stake in Unilever’s (ULVR.L) Indian business (HLL.NS) for about 254.8 billion rupees ($3.35 billion) on the open market, cashing in late from the sale of the Horlicks brand. (reut.rs/3fvie8r)

Reporting by Pushkala Aripaka in Bengaluru; Editing by Anil D’Silva

Our Standards:The Thomson Reuters Trust Principles.
source: reuters.com